Drug to slow early-stage Alzheimer's disease approved by Health Canada
October 28, 2025
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of Alzheimer's disease.
Unpublished Newswire
Police in Waterloo charged a teenage girl in connection with the collision that sent four youths to hospital earlier this month.
October 31, 2025 - 07:17 | Globalnews Digital | Global News - Canada
Police in Waterloo charged a teenage girl in connection with the collision that sent four youths to hospital earlier this month.
October 31, 2025 - 07:17 | Globalnews Digital | Global News - Ottawa
October 31, 2025 - 07:15 | | CBC News - Canada
Comments
Be the first to comment